Expanded access for iberdomide
Treatments studied
This is a special program that lets people with serious blood conditions try an investigational drug called iberdomide when no other treatments are available. It's not a clinical trial—it's a way to request early access to a promising medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a serious condition that iberdomide is meant to treat.
- You must have no other approved treatment options left to try.
- Your doctor must contact the company to request access for you.
- You must be under a doctor's care who is willing to monitor you closely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers expanded access to mezigdomide for patients who have exhausted other treatment options. It may help those with certain cancers, though the exact details are not listed.
This trial tests adding a new drug called iberdomide to standard treatment for children and young adults with neuroblastoma that has returned or not responded. The goal is to see if it helps control the cancer better than usual therapy alone.
This Phase 2 study tests iberdomide alone or with low-dose dexamethasone in people with intermediate- or high-risk “smoldering” multiple myeloma. The goal is to see if the treatment can control or delay progression to active myeloma.
This early-stage study tests whether giving a drug called iberdomide before collecting cells for CAR-T therapy can make the cells healthier and more effective in treating multiple myeloma that has come back or hasn't responded to previous treatments.
This trial tests a new combination of two drugs (teclistamab and iberdomide) for people with multiple myeloma that has come back or stopped responding to standard treatments. The goal is to see how well this combination works and whether it can help control the disease.
This is an expanded access program, also known as compassionate use, which allows patients with serious conditions to try an investigational drug when no other options are available. The trial tests a treatment called ITM11, but the specific details are not listed, so your doctor would need to contact the company for more information.